Agilent Technologies Announces Pricing of $500 Million of Senior Notes SANTA CLARA, Calif., September 5, 2019 Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $500 million. The offering is being conducted under an automatic shelf registration... Read more
Agilent Collaborates on Groundbreaking Study of Performance-Enhancing Spinach Extract Freie Universität Berlin uses company’s cutting-edge tools to examine effects of ecdysterone SANTA CLARA, Calif., September 3, 2019 Agilent Technologies Inc. (NYSE: A) today announced that its instruments and expertise contributed to a groundbreaking study commissioned by the World Anti-Doping Agency, or WADA. Researchers at Freie... Read more
Agilent Presents Thought Leader Award toProfessor Hyun Joo An Korean researcher recognized for her work in glycomics and biopharma applications SANTA CLARA, Calif., August 28, 2019 Agilent Technologies, Inc. (NYSE: A)announced today that Professor Hyun Joo An has received an Agilent Thought Leader Award in support of her work in glycomics and biopharmaceutical applications. Dr.... Read more
Agilent Technologies Releases 2018 Corporate Social Responsibility Report Leading global life sciences and diagnostics company invests more than $7M in sustainability and $9M in philanthropic initiatives SANTA CLARA, Calif., August 28, 2019 Agilent Technologies, Inc. (NYSE: A) today announced the launch of its 18th annual Corporate Social Responsibility (CSR) report which discusses sustainability activities and... Read more
Agilent Completes Acquisition of BioTek Instruments Builds on Multi-Year Growth Strategy in Critical Cell Analysis Technology SANTA CLARA, Calif., August 26, 2019 Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and distribution of innovative life science instrumentation. The BioTek acquisition expands... Read more
Builds on Multi-Year Growth Strategy in Critical Cell Analysis Technology SANTA CLARA, Calif., August 26, 2019 Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and distribution of innovative life science instrumentation. The BioTek acquisition expands Agilent’s growing presence and expertise in... Read more
Agilent OFS Academy Receives Learning!100 Award for Third Consecutive Year Company recognized for its efforts to develop employee talents SANTA CLARA, Calif., August 19, 2019 Agilent Technologies Inc. (NYSE: A) today announced it has received a Learning!100 Award from Elearning! Media Group (EMG). This is the third year in a row that EMG has recognized... Read more
NUS, Agilent, and NUH launch new translational R&D hub to boost clinical diagnostics S$38 million research facility aims to be a premier, global, one-stop hub for research and translation to clinical testing through biochemical innovation and techniques Singapore, 19 August 2019 The National University of Singapore (NUS), Agilent Technologies, a global leader in life sciences,... Read more
Agilent Presents Thought Leader Award to Professor Gang Yu Influential Tsinghua researcher recognized for his work in environmental science and engineering related to emerging organic contaminants in water SANTA CLARA, Calif., Aug. 15, 2019 Agilent Technologies Inc. (NYSE: A) today announced that Dr. Gang Yu, a professor at the School of Environment at Tsinghua University... Read more
Agilent Introduces Revolutionary Real-Time Cell Analyzer Multiplex assay combines non-invasive biosensor measurement with live cell imaging SANTA CLARA, Calif., Aug. 15, 2019 Agilent Technologies Inc. (NYSE: A) today introduced a multimode real-time cell analyzer (RTCA)—the first of its kind—combining the best of non-invasive biosensor measurement with live cell imaging. “The xCELLigence RTCA eSight will revolutionize... Read more